Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 203

1.

The role of pre-existing diabetes mellitus on hepatocellular carcinoma occurrence and prognosis: a meta-analysis of prospective cohort studies.

Yang WS, Va P, Bray F, Gao S, Gao J, Li HL, Xiang YB.

PLoS One. 2011;6(12):e27326. doi: 10.1371/journal.pone.0027326. Epub 2011 Dec 21.

PMID:
22205924
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Increased risk of hepatocellular carcinoma in patients with diabetes mellitus: a systematic review and meta-analysis of cohort studies.

Wang C, Wang X, Gong G, Ben Q, Qiu W, Chen Y, Li G, Wang L.

Int J Cancer. 2012 Apr 1;130(7):1639-48. doi: 10.1002/ijc.26165. Epub 2011 Jul 28. Review.

PMID:
21544812
[PubMed - indexed for MEDLINE]
3.

Differential mechanism and prognostic impact of diabetes mellitus on patients with hepatocellular carcinoma undergoing surgical and nonsurgical treatment.

Huo TI, Wu JC, Lui WY, Huang YH, Lee PC, Chiang JH, Chang FY, Lee SD.

Am J Gastroenterol. 2004 Aug;99(8):1479-87.

PMID:
15307864
[PubMed - indexed for MEDLINE]
4.

Diabetes mellitus as an independent prognostic predictor and its association with renal dysfunction in patients with hepatocellular carcinoma.

Huo TI, Hsu CY, Huang YH, Hsia CY, Lin HC, Lee PC, Loong CC, Chiang JH, Chiou YY, Lee SD.

Liver Int. 2010 Feb;30(2):198-207. doi: 10.1111/j.1478-3231.2009.02143.x. Epub 2009 Oct 22.

PMID:
19849777
[PubMed - indexed for MEDLINE]
5.

Prognostic role of diabetes mellitus in hepatocellular carcinoma patients after curative treatments: a meta-analysis.

Wang WM, Xu Y, Yang XR, Wang YH, Sun HX, Fan J.

Hepatobiliary Pancreat Dis Int. 2011 Aug;10(4):346-55. Review.

PMID:
21813381
[PubMed - indexed for MEDLINE]
Free Article
6.

Increased international normalized ratio level in hepatocellular carcinoma patients with diabetes mellitus.

Zhang H, Gao C, Fang L, Yao SK.

World J Gastroenterol. 2013 Apr 21;19(15):2395-403. doi: 10.3748/wjg.v19.i15.2395.

PMID:
23613635
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Metformin and reduced risk of hepatocellular carcinoma in diabetic patients: a meta-analysis.

Zhang H, Gao C, Fang L, Zhao HC, Yao SK.

Scand J Gastroenterol. 2013 Jan;48(1):78-87. doi: 10.3109/00365521.2012.719926. Epub 2012 Nov 9.

PMID:
23137049
[PubMed - indexed for MEDLINE]
8.

Risk of hepatocellular carcinoma in diabetic patients and risk reduction associated with anti-diabetic therapy: a population-based cohort study.

Lai SW, Chen PC, Liao KF, Muo CH, Lin CC, Sung FC.

Am J Gastroenterol. 2012 Jan;107(1):46-52. doi: 10.1038/ajg.2011.384. Epub 2011 Nov 15.

PMID:
22085817
[PubMed - indexed for MEDLINE]
9.

Diabetes mellitus is a risk factor for hepatic decompensation in patients with hepatocellular carcinoma undergoing resection: a longitudinal study.

Huo TI, Lui WY, Huang YH, Chau GY, Wu JC, Lee PC, Chang FY, Lee SD.

Am J Gastroenterol. 2003 Oct;98(10):2293-8.

PMID:
14572582
[PubMed - indexed for MEDLINE]
10.

Diabetes mellitus: a "true" independent risk factor for hepatocellular carcinoma?

Gao C, Yao SK.

Hepatobiliary Pancreat Dis Int. 2009 Oct;8(5):465-73. Review.

PMID:
19822488
[PubMed - indexed for MEDLINE]
Free Article
11.

Diabetes mellitus and risk of hepatocellular carcinoma: a systematic review and meta-analysis.

Wang P, Kang D, Cao W, Wang Y, Liu Z.

Diabetes Metab Res Rev. 2012 Feb;28(2):109-22. doi: 10.1002/dmrr.1291. Review.

PMID:
21898753
[PubMed - indexed for MEDLINE]
12.

Highlights for α-fetoprotein in determining prognosis and treatment monitoring for hepatocellular carcinoma.

Xu XS, Qu K, Liu C, Zhang YL, Liu J, Song YZ, Zhang P, Liu SN, Chang HL.

World J Gastroenterol. 2012 Dec 28;18(48):7242-50. doi: 10.3748/wjg.v18.i48.7242.

PMID:
23326129
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Increased risk of hepatocellular carcinoma among patients with hepatitis C cirrhosis and diabetes mellitus.

Veldt BJ, Chen W, Heathcote EJ, Wedemeyer H, Reichen J, Hofmann WP, de Knegt RJ, Zeuzem S, Manns MP, Hansen BE, Schalm SW, Janssen HL.

Hepatology. 2008 Jun;47(6):1856-62. doi: 10.1002/hep.22251.

PMID:
18506898
[PubMed - indexed for MEDLINE]
14.

The role of preexisting diabetes mellitus on incidence and mortality of endometrial cancer: a meta-analysis of prospective cohort studies.

Zhang ZH, Su PY, Hao JH, Sun YH.

Int J Gynecol Cancer. 2013 Feb;23(2):294-303. doi: 10.1097/IGC.0b013e31827b8430.

PMID:
23287960
[PubMed - indexed for MEDLINE]
15.

Anti-diabetic medications and the risk of hepatocellular cancer: a systematic review and meta-analysis.

Singh S, Singh PP, Singh AG, Murad MH, Sanchez W.

Am J Gastroenterol. 2013 Jun;108(6):881-91; quiz 892. doi: 10.1038/ajg.2013.5. Epub 2013 Feb 5. Review.

PMID:
23381014
[PubMed - indexed for MEDLINE]
16.

Chronic hepatitis C increased the mortality rates of patients with hepatocellular carcinoma and diabetes mellitus in a triple hepatitis virus endemic community.

Chang KC, Tsai PS, Hsu MC, Hung SF, Tsai CC, Lu SN.

J Gastroenterol. 2010 Jun;45(6):636-45. doi: 10.1007/s00535-009-0189-5. Epub 2010 Jan 7.

PMID:
20054698
[PubMed - indexed for MEDLINE]
17.

Diabetes mellitus is associated with increased mortality in patients receiving curative therapy for hepatocellular carcinoma.

Shau WY, Shao YY, Yeh YC, Lin ZZ, Kuo R, Hsu CH, Hsu C, Cheng AL, Lai MS.

Oncologist. 2012;17(6):856-62. doi: 10.1634/theoncologist.2012-0065. Epub 2012 May 23.

PMID:
22622151
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Association of type II diabetes mellitus with hepatocellular carcinoma occurrence--a case control study from Kathmandu Valley.

Jha DK, Mittal A, Gupta SP, Pandeya DR, Sathian B.

Asian Pac J Cancer Prev. 2012;13(10):5097-9.

PMID:
23244117
[PubMed - indexed for MEDLINE]
Free Article
19.

Prognosis of diabetic patients undergoing coronary artery bypass surgery compared with nondiabetics: a systematic review and meta-analysis.

Zhang X, Wu Z, Peng X, Wu A, Yue Y, Martin J, Cheng D.

J Cardiothorac Vasc Anesth. 2011 Apr;25(2):288-98. doi: 10.1053/j.jvca.2010.09.021. Epub 2010 Dec 13.

PMID:
21147538
[PubMed - indexed for MEDLINE]
20.

Diabetes mellitus impacts risk of macrovascular invasion in patients undergoing transplantation for hepatocellular carcinoma.

Connolly GC, Safadjou S, Kashyap R, Chen R, Orloff MS, Hezel AF.

BMC Gastroenterol. 2013 Jan 14;13:9. doi: 10.1186/1471-230X-13-9.

PMID:
23317091
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk